From bench to bedside: Evolving therapeutic targets in autoimmune blistering disease

EH Kowalski, D Kneiber… - Journal of the …, 2019 - Wiley Online Library
Autoimmune blistering diseases comprise a group of heterogenous conditions characterized
by the loss of tolerance and subsequent development of autoantibodies targeting epidermal …

From bench to bedside: evolving therapeutic targets in autoimmune blistering disease.

K Kridin, EH Kowalski, D Kneiber… - Journal of the …, 2019 - europepmc.org
Autoimmune blistering diseases comprise a group of heterogenous conditions characterized
by the loss of tolerance and subsequent development of autoantibodies targeting epidermal …

From bench to bedside: evolving therapeutic targets in autoimmune blistering disease

K Kridin, EH Kowalski, D Kneiber… - Journal of the …, 2019 - pubmed.ncbi.nlm.nih.gov
Autoimmune blistering diseases comprise a group of heterogenous conditions characterized
by the loss of tolerance and subsequent development of autoantibodies targeting epidermal …